Search Results
May 18, 2026, 07:00 ET Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)
asthma, atopic dermatitis, eosinophilic esophagitis, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease." Zhenping Zhu, MD, PhD, President & Co-CEO of Earendil Labs, commented, "HXN-1011 represents a highly differentiated next-generation TSLP antagonist with the best-in-class
More news about: Earendil Labs
May 18, 2026, 07:00 ET Apnimed Announces Publication of its Phase 3 SynAIRgy Trial of AD109 for Obstructive Sleep Apnea in the American Journal of Respiratory and Critical Care Medicine
complex and heterogeneous disease. A one-size-fits-all approach has left many people with OSA without a treatment that works for them," said Neomi Shah MD, MPH, MSc, ATSF, Chair of the Sleep and Respiratory Neurobiology Assembly at American Thoracic Society. "Advances that connect clinical outcomes with
More news about: Apnimed, Inc.
May 18, 2026, 04:31 ET 康霈首登 ECO 2026 口頭發表 CBL-514 併用 GLP-1R 類減重藥物動物數據 全身性代謝效果吸引國際專家及大藥廠高度興趣
肝臟代謝指標改善 潛力康霈局部減脂新藥 CBL-514 併用 GLP-1R 類減重藥物之動物實驗數據，已於5月14日歐洲肥胖症大會（ECO 2026）完成口頭發表，由國際知名肥胖醫學權威、康霈科學顧問 Arya Sharma, MD 擔任講者，向全球肥胖與代謝醫學專家分享 CBL-514 於減重減脂與代謝應用之潛在科學價值。研究結果顯示，CBL-514 不論併用Semaglutide 或 Tirzepatide，於動物實驗中展現增強減重效果、減緩停藥後復胖，並進一步減少皮下脂肪與內臟脂肪之潛力。本次發表亦首度揭示：CBL-514
More news about: 康霈生技
May 17, 2026, 10:57 ET USHG CEO Chip Wade named 2026 Gold Plate winner
Hochman (2025).In addition to Wade, 2026 Silver Plate recipients are:Leisa Bryant, executive director at the University of Texas MD Anderson Cancer Center, in the category of Healthcare, nominated by Ecolab, ITW and PepsiCoDanielle Bock, director for Nutrition Services
More news about: IFMA The Food Away from Home Association
May 16, 2026, 14:54 ET The Aesthetic Society Names Dr. Jamil Ahmad as President of The Aesthetic Society and Dr. David Sieber as President of The Aesthetic Foundation at The Aesthetic MEET 2026
The Aesthetic Society® has named Jamil Ahmad, MD, as its new President at
More news about: The Aesthetic Society
May 15, 2026, 16:05 ET Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
Health and Accuray will build on this shared history to advance the next generation of adaptive radiotherapy approaches, according to Zachary Morris, MD, PhD, professor and chair of human oncology. "At UW we have exceptionally talented innovators in radiation medicine across the spectrum from discovery
More news about: Accuray Incorporated
May 15, 2026, 16:01 ET Propedix Announces Appointment of Dr. Mercedes E. Gonzalez to its Clinical Advisory Board
May 15, 2026 /PRNewswire/ -- Propedix today announced the appointment of board-certified pediatric dermatologist Dr. Mercedes E. Gonzalez, MD, to its Clinical Advisory Board, effective immediately.
More news about: Propedix Inc.
May 15, 2026, 13:44 ET Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss
financial results for the 2026 first quarter ended March 31, 2026, all figures are in CAD unless otherwise indicated. The financial statements and MD&A are available on
More news about: Else Nutrition Holdings Inc.
May 15, 2026, 12:35 ET Federal Realty to Webcast 2026 Investor Day Presentation
NORTH BETHESDA, Md., May 15, 2026 /PRNewswire/ --
More news about: Federal Realty Investment Trust
May 15, 2026, 12:29 ET एशिया में LNG की मांग, निवेश और प्रणालीगत परिवर्तन में तेजी आने के साथ, Gastech 2026 बैंकॉक में वैश्विक ऊर्जा नेताओं को एक साथ लाएगा।
महासचिव, अंतर्राष्ट्रीय ऊर्जा मंचDr. Narin Phoawanich, गवर्नर, ईजीएटीDr. Kongkrapan Intarajang, CEO और अध्यक्ष, PTTLiz Westcott, MD & CEO, वुडसाइड एनर्जीLorenzo Simonelli, चेयरमैन, प्रेसिडेंट और CEO, बेकर ह्यूजेसTakayuki Ueda, अध्यक्ष और CEO, INPEX Corporationसम्मेलनों
More news about: dmg events
May 15, 2026, 10:00 ET SightMD Pennsylvania Welcomes Katlyn Kozell, OD to Wyomissing and Pottsville Locations
team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact the Chief Medical Officer, Brad Kligman, MD, at [email protected] SightMD PennsylvaniaSightMD
More news about: SightMD
May 15, 2026, 09:10 ET Tripmasters Expands with New Experience-Focused Vacation Packages Designed for Stress-Free Travel
slower, experience-driven vacations with fewer hotel changes and deeper destination immersionSILVER SPRING, Md., May 15, 2026 /PRNewswire/ --
More news about: Tripmasters
May 15, 2026, 08:30 ET Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek
James Hamrick, MD, MPH, Chairman, Caris Precision Oncology Alliance. "The Caris Lookback Program was designed to extend the clinical value of comprehensive molecular
More news about: Caris Life Sciences
May 15, 2026, 08:00 ET Allergy & Asthma Network to Highlight Patient-Centered Research and Health Equity at the American Thoracic Society 2026 International Conference
which will be presented during the PAR Abstract Reception on Sunday, May 17, from 6 – 9 p.m. ET. This year's recipient is Patricia Andrea Dela Cruz, MD, Ph.D.Media Interview OpportunitiesAllergy & Asthma Network experts are available for interviews, background conversations, and
More news about: Allergy & Asthma Network
May 15, 2026, 07:36 ET Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting
Ziegelmann, MD; Billy H. Cordon, MD; Majdee M. Islam, MD; Alexander J. Tatem, MD; Richard C. Bennett, MD; Faysal A. Yafi, MD, FRCSC; Peter Bajic, MD; Nelson E. Bennett, Jr., MD; Helen L. Bernie, DO, MPH; Marcelo Mass-Lindenbaum, MD; Muhammed A. M. Hammad, MBBCh, MS; Kristen Gumpf, PA-C; David Hurley, MD; Jeffrey
More news about: Keenova Therapeutics
May 15, 2026, 06:30 ET Starget Pharma, caVos Biotherapeutics, Protai and BAIBYS™ Awarded Most Innovative Life Science Startups at Biomed Israel 2026
Neta-li Feuerstein Ganor, Eli Lilly; Adar Makovski Silverstein, PhD, Arkin Bio Ventures; Yael Gruenbaum-Cohen, PhD, Entree Bio Ventures; Irit Yaniv, MD, Almeda; Joseph Korff, ARC Ventures; Yair Benita, PhD, AION labs; Peter Kash, PhD, Camelot BioCapital and Amir Blatt, JJDC.
More news about: Biomed Israel
May 15, 2026, 06:12 ET Nava Records Its Highest-Ever Jump in Standalone Profit at 116%, Reaching ₹911 Crore
activities at the Kawambwa Sugar Project, making FY26 one of the Company's most active growth phases.Commenting on the performance, Ashwin Devineni, MD & CEO, said:"This has been a strong year for Nava, with our standalone profit growing by over 100% and our businesses continuing to deliver
More news about: Nava Limited
May 15, 2026, 03:43 ET NAL Academy collaborates with QuantInsti to strengthen India's Algorithmic and Quantitative Investing Ecosystem
actionable insights and peer learning opportunities to stay ahead in a rapidly evolving, technology-driven financial environment.NAL Academy Ltd. MD & CEO, Mr. Abhilash Misra, stated: "We are excited to partner with QuantInsti as this initiative aligns to our mission of building future-ready talent in
More news about: QuantInsti
May 15, 2026, 00:36 ET FRONTERA ANNOUNCES FIRST QUARTER 2026 RESULTS
to the "Discontinued Operations" section on page 8 of the Company's Management Discussion & Analysis for the three months ended March 31, 2026 MD&A for further details.** As
More news about: Frontera Energy Corporation
May 14, 2026, 20:48 ET The ADDF Highlights Encouraging Progress Toward Targeting Multiple Alzheimer's Pathologies in Biogen's Phase 2 Tau Study
meaningful progress with amyloid-targeted therapies, and these results suggest the field is moving closer to doing the same for tau," said Howard Fillit, MD, Co-Founder and Chief Science Officer of the ADDF. "While we need to see the full data, diranersen is the first therapy of its kind to reach this stage,
More news about: Alzheimer's Drug Discovery Foundation
May 14, 2026, 17:22 ET DENARIUS METALS FILES FIRST QUARTER 2026 INTERIM FINANCIAL STATEMENTS, INTERIM MD&A AND ZANCUDO TECHNICAL REPORT ON SEDAR+
announced today that it has filed its unaudited interim condensed consolidated financial statements and accompanying management's discussion and analysis (MD&A) for the three months ended March 31, 2026. These documents can be found on its website at
More news about: Denarius Metals Corp.
May 14, 2026, 17:16 ET PROCURE INTRODUCES NEW AWARENESS INITIATIVE TO EDUCATE PATIENTS ABOUT PROTON THERAPY
care journey."Too often, patients don't learn about proton therapy until late in the treatment-decision process—if at all," said Brian Chon, MD. "Our goal is to help people better understand their options so they can have more informed conversations with their cancer care team."By precisely
More news about: ProCure Proton Therapy Center
May 14, 2026, 16:30 ET METALLA REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2026 AND PROVIDES ASSET UPDATES
Castle MountainOn May 6, 2026, Equinox Gold Corp. ("Equinox") reported in its first quarter MD&A that it expects to release an updated feasibility study for Castle Mountain in the second half of 2026. Equinox stated that it is focused on advancing
More news about: Metalla Royalty & Streaming Ltd.
May 14, 2026, 16:15 ET McCormick Honors 2026 Unsung Heroes; Awards $105,000 in Total Scholarships to Student-Athletes
Tempris Harrison from Frederick Douglass High School and Avery Ray from Franklin High SchoolHUNT VALLEY, Md., May 14, 2026 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE: MKC), a global leader in flavor, announced
More news about: McCormick & Company, Incorporated
May 14, 2026, 16:13 ET American Society of Gene and Cell Therapy Awards Beverly L. Davidson, PhD, Outstanding Achievement Award
Susan Furth, MD, PhD, Executive Vice President and Chief Scientific Officer at CHOP. "Her leadership has transformed how the field develops and delivers brain‑directed
More news about: Children's Hospital of Philadelphia